HOTH יחס מהיר Hoth Therapeutics Inc.

Hoth Therapeutics, Inc. (HOTH) adheres to ESG principles by reducing laboratory emissions and maintaining bioethical standards during testing. The business relies on investments to develop advanced treatments for psoriasis and skin cancer. This price chart reflects the asset's dynamics, where the indicator stands at 3.47. The company's strategy is based on clinical trials with the goal of subsequently selling licenses to pharmaceutical behemoths following FDA approval.

This metric measures the ability of Hoth Therapeutics, Inc. (HOTH) to instantaneously settle short-term debts using its most liquid assets, completely excluding low-liquidity inventories from the calculation. By analyzing the absolute liquidity ratio, an investor assesses the company's financial reserve required to maintain costly ESG standards for chemical emission filtration and the modernization of energy-saving systems in biotechnological laboratories.